Background The risks associated with using an angiotensin-converting-enzyme (ACE)
inhibitor and an angiotensin-receptor blocker together are unclear. This study was designed …

Angiotensin-converting enzyme (ACE) inhibitors decrease mortality and cardiovascular
events in patients with cardiovascular disease or high-risk diabetes and slow the …

Renin and aldosterone activity levels are low in elderly patients, raising concerns about the
benefits and risks of angiotensin-converting-enzyme inhibitors (ACEIs) and angiotensin II …

The comparative efficacy and safety of angiotensin-converting enzyme inhibitors (ACEIs)
with other agents in patients≥ 65 years of age with cardiovascular diseases or at-risk are …

Angiotensin-converting enzyme inhibitors and angiotensin II–receptor antagonists are
recommended for patients with chronic kidney disease because these drugs can slow …

Background Treatment of hypertension with diuretics, beta-blockers, or both leads to
improved outcomes. It has been postulated that agents that inhibit the renin–angiotensin …

OBJECTIVE: To evaluate the dose‐related benefit of angiotensin‐converting enzyme (ACE)
inhibitor therapy among older adults with heart failure and to evaluate whether low‐dose …

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers are commonly
prescribed for the management of hypertension. In addition, each of these drug classes has …

BACKGROUND The efficacy and safety of angiotensin receptor blockers (ARBs) in the older
population is unclear. OBJECTIVES To determine the efficacy and safety of ARBs in older …

The OSCAR study was a multicenter, prospective randomized open-label blinded end-point
study of 1164 Japanese elderly hypertensive patients comparing the efficacy of angiotensin …